BURLINGAME, Calif., July 6, 2018 /PRNewswire-PRWeb/ -- AHNP Precision Health is announcing its acquisition of the MPI
As part of the acquisition, Dr. Bredesen will be joining AHNP as Chief Scientist for Brain Health at AHNP and as a member of the Board. "Alzheimer's disease is now one of the leading causes of death in the United States, and we have shown that computer-based algorithms can be powerful allies in the prevention and reversal of cognitive decline. The outstanding team at AHNP will bring about optimization and scaling of this approach, reaching so many who are in critical need of prevention or reversal of cognitive decline," says Bredesen.
"All of us at AHNP believe that we are at the beginning of a revolution in understanding, preventing, and treating epidemic chronic disease. Our part in this revolution is to offer a new synthesis of diagnostics, technology, education, coaching, and behavior change methodology for physicians, clients, and patients. Having Dr. Bredesen join our team is a giant step forward for AHNP, but more importantly, for the thousands of people who want to take a strong stand against cognitive decline," said Steve Baumgartner, CEO and Co-Chairman of the Board of AHNP.
"We are thrilled to be combining Dr. Bredesen's groundbreaking science with the AHNP technology platform to build accessible products that will help people prevent, manage, and reverse the symptoms of cognitive decline worldwide," says Lance Kelly, CTO and Co-Chairman of the Board of AHNP.
The acquisition of MPI Cognition's business is designed to bring multi-modal treatment to thousands initially and then hundreds of thousands of clients, patients, and their physicians over the course of the next few years through a series of products built on AHNP's sophisticated technology platform and a ground-breaking, integrated human platform.
AHNP Precision Health is a patient engagement company focused on precision health that empowers patients, practitioners, hospitals, universities, and corporations to prevent and reverse behavior-related or exposure-related chronic diseases through advanced medical information, algorithms, and scientifically supported behavior modification. For more information, please visit our website at: https://www.ahnphealth.com.
SOURCE AHNP Precision Health
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All